Skip to main content

Bacterial Etiology of Inflammatory Disease

  • Chapter
Inflammatory Bowel Diseases 1986

Part of the book series: Developments in Gastroenterology ((DIGA,volume 8))

Abstract

Bacteria have been implicated in the pathogenesis of inflammatory bowel disease (IBD) for several decades, beginning with conventional pathogens such as Shigella, and moving to the current, more “trendy” organisms such as L-forms and mycobacteria. It is only natural to consider bacteria as potential culprits in these diseases, since the intestinal mucosa forms the fragile border between the flora of the lumen and the host’s tissues. In addition, the gut is threatened on a daily basis by microorganisms from the environment that gain passage through vehicles of food and drink. Besides these écologic considerations, the histopathologic features of IBD are strikingly reminiscent of conventional infectious diseases, albeit of an acute and self-limited nature. Ulcerative colitis (UC) is not unlike acute bacillary dysentery, while Crohn’s disease (CD) bears resemblance to intestinal tuberculosis and Yersinia infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Donaldson, RM, Jr. 1964. Normal bacterial population of the intestine and their relation to intestinal function. New England Journal of Medicine 270: 938, 946, 994: 1000, 1050.

    Article  PubMed  Google Scholar 

  2. Donaldson, RM, Jr. 1970. Small bowel bacterial overgrowth. Advances in Internal Medicine 16: 191–212.

    PubMed  Google Scholar 

  3. Floch MH, Gorbach SL and Luckey TD. 1970. Symposium: Intestinal microbiology. American Journal of Clinical Nutrition 23: 1425–1609.

    PubMed  CAS  Google Scholar 

  4. Gorbach SL. 1971. Intestinal microflora. Gastroenterology 60: 1110–29.

    PubMed  CAS  Google Scholar 

  5. Simon G, and Gorbach SL. 1985. Intestinal flora and gastrointestinal function. IN: Physiology of the Gastrointestinal Tract.

    Google Scholar 

  6. Maier BR et al. 1972. Shigella, indigenous flora interactions in mice. American Journal of Clinical Nutrition 25: 1433–40.

    PubMed  CAS  Google Scholar 

  7. Gorbach SL, Neale G, Levitan R, and Hepner GW. 1970. Alterations in human intestinal microflora during experimental diarrhea. Gut 11: 1–6.

    Article  PubMed  CAS  Google Scholar 

  8. Bargen JA. 1924. Experimental studies on etiology of chronic ulcerative colitis. Journal of American Medical Association 83: 332–36.

    Google Scholar 

  9. Dragstedt LR, Dack GM, and Kirsner JB. 1941. Chronic ulcerative colitis. A summary of evidence implicating Bacterium necrophorum as an etiologic agent. Annals of Surgery 114: 653–662.

    PubMed  CAS  Google Scholar 

  10. Meleney F. 1941. Discussion. Annals of Surgery 114: 661–62.

    Article  Google Scholar 

  11. Gorbach SL et al. 1968. Studies of intestinal microflora: V. fecal microbial ecology in ulcerative colitis and regional enteritis; relationship to severity of disease and chemotherapy. Gastroenterology 54: 575–87.

    PubMed  CAS  Google Scholar 

  12. Danielsson D, Kjellander J, and Jarnerot G. 1981. The effect of metronidazole and sulfasalazine on the fecal flora in patients with Crohn’s Disease. Scand J Gastroenterol 16:(2): 183–92.

    Article  PubMed  CAS  Google Scholar 

  13. Hudson MJ, Hill MJ, Elliott PR, Berghouse LM, Burnham WR, and Lennard-Jones JE. (1984). The microbial flora of the rectal mucosa and faeces of patients with Crohn’s disease before and during antimicrobial chemotherapy. J Med Microbiol l8(3): 335–45.

    Article  Google Scholar 

  14. Cooke EM. 1967. A quantitative comparison of the fecal flora of patients with ulcerative colitis and that of normal persons. Journal of Pathological Bacteriology 91: 439–44.

    Article  Google Scholar 

  15. Van der Wiel-Korstangie JA, and Winkler KC. 1975. The fecal flora in ulcerative colitis. Journal of Medical Microbiology 8: 491–501.

    Article  Google Scholar 

  16. Van der Merwe M, and Mol GJJ. 1980. A possible role of Eubacterium and Peptostreptococcus species in the etiology of Crohn’s disease. Ant. Van Leeuwenhock 46: 597–93.

    Google Scholar 

  17. Ambrose NS, Johnson M, Burdon DW, and Keighly MRB. 1984. British Journal of Surgery 71: 623–625.

    Article  PubMed  CAS  Google Scholar 

  18. Cooke EM. 1968. Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons. J. Pathol. Bacteriol. 95: 101–113.

    Article  PubMed  CAS  Google Scholar 

  19. Dickinson RJ, Varian SA, Axon AT, and Cooke EN. 1980. Increased incidence of fecal conforms with in vitro adhesive and invasive properties in patients with ulcerative colitis Abstract. Gut 21(9): 787–92.

    Article  PubMed  CAS  Google Scholar 

  20. Rutgeerts P, Ghoos Y, Vantrappen G, and Eyssen H. 1981. Ileal dysfunction and bacterial overgrowth in patients with Crohn’s disease. Eur J Clin Invest 11(3): 199–206.

    Article  PubMed  CAS  Google Scholar 

  21. Brown WR, and Lee E. 1973. Radioimmunological measurements of naturally occurring bacterial antibodies. I. Human serum antibodies reactive with Escherichia coli in gastrointestinal and immunologic disorders. J Lab Clin Med 82: 125–36.

    PubMed  CAS  Google Scholar 

  22. Tabaqchali S, O’Donoghue DP, and Bettelheim KA. 1978. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut 19: 108–13.

    Article  PubMed  CAS  Google Scholar 

  23. Persson S, and Danielsson D. 1979. On the occurrence of serum antibodies to Bacteroides fragilis and serogroups of E. coli in patients with Crohn’s disease. Scand J Infect Dis (Suppl)(19): 61–7.

    Google Scholar 

  24. Brown WR, and Lee E. 1974. Radioimmunological measurements of bacterial antibodies. Human serum antibodies reactive with Bacteroides fragilis and enterococcus in gastrointestinal and immunological disorders. Gastroenterology 66: 1145–53.

    PubMed  CAS  Google Scholar 

  25. Mathews N, Mayberry JF, Rhodes J, et al. 1980. Agglutinins to bacteria in Crohn’s disease. Gut 21: 376–80.

    Article  Google Scholar 

  26. Auer IO, Roder A, Wensinck F, Van de Merwe JP, and Schmidt H. 1983. Selected bacterial antibodies in Crohn’s disease and ulcerative colitis. Scand J Gastroenterol 18: 217–23.

    Article  PubMed  CAS  Google Scholar 

  27. Weinsinck F, van de Merwe JP, and Mayberry JF. 1983. Abstract. An international study of agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species in Crohn’s disease, ulcerative colitis and control subjects. Digestion 27(2): 63–9.

    Article  Google Scholar 

  28. Gump D, Caul E, Eade O, Greenberg H, Kapikian, MacPherson B, Mitchell P, Parent K, Richmond S and Beeken W. 1981. Lymphocytotoxic and microbial antibodies in Crohn’s disease and matched controls. Ant. Van Leeuwenhock 46: 597–93.

    Google Scholar 

  29. Onderdonk AB, Steeves RM, Cisneros RL, and Bronson RT. 1984. Adoptive transfer of immune enhancement of experimental ulcerative colitis. Infection and Immunity 46(1): 64–7.

    Google Scholar 

  30. Kirsner and Shorter. 1982. Recent developments in “ nonspecific” inflammatory disease. New England Journal of Medicine 306: 775–784, 837-848.

    Article  Google Scholar 

  31. Hurst AF. 1921. Ulcerative colitis. Guy Hospital Republic 71: 26–44.

    Google Scholar 

  32. Mackie TT. 1932. Ulcerative colitis due to chronic infection with Flexner-bacillus. Journal of American Medical Association 98: 1706–10.

    Google Scholar 

  33. Felson J, and Wolarsky W. 1953. Acute and chronic bacilliary dysentery and chronic ulcerative colitis. Journal of American Medical Association 153: 1069–72.

    Google Scholar 

  34. Fradkin WZ. 1937. Ulcerative colitis: Bacterial aspects. New York Journal of Medicine 37: 249–52.

    Google Scholar 

  35. Blaser MJ, Miller FA, Lacher J, and John W. Singleton. 1984. Patients with active Crohn’s disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 87: 888–94.

    PubMed  CAS  Google Scholar 

  36. Grange JM, Gibson J, Nassau E, and Kardjito T. 1980. Enzyme-linked immunosorbent assay (ELISA): a study of antibodies to Mycobacterium tuberculosis in the IgG, IgA and IgM classes in tuberculosis, sarcoidosis, and Crohn’s disease. Tubercule 61: 145–52

    Article  CAS  Google Scholar 

  37. Swabrick FP, Price NL, Kingham JGC et al. 1979. Chlamydia, cytomegalovirus and Yersinia in inflammatory bowel disease. Lancet 11–12.

    Google Scholar 

  38. Taylor-Robinson D, O’Morain CA, and Thomas BJ. 1979. Low frequency of chlamydial antibodies in patients with Crohn’s disease and ulcerative colitis. Lancet i: 1162–65.

    Article  Google Scholar 

  39. Munro J, Mayberry JF, Matthews N, et al. 1979. Chlamydia and Crohn’s disease. Lancet ii: 45–46.

    Article  Google Scholar 

  40. Mardh PA, Ursing B, and Sandgren E. 1980. Lack of evidence for an association between infection with Chlamydia trachomatis and Crohn’s disease, as indicated by microimmunofluorescence antibody test. Acta Pathol Microbiol Scand (B) 88(1): 57–9.

    CAS  Google Scholar 

  41. Bartlett JG, Chang TW, Gurwith M, et al. 1978. Antibiotic-associated pseudomembranous colitis due to toxin producing clostridia. New England Journal of Medicine 298: 531–4.

    Article  PubMed  CAS  Google Scholar 

  42. Bartlett JG, and Chang TW. 1979. Colitis induced by clostridium difficile. The Reviews of Infectious Diseases.

    Google Scholar 

  43. Trinka F, Markham R, Gurwith et al. 1978. Oral vancomycin for antibiotic association pseudomembranous colitis. Lancet i: 97–8.

    Google Scholar 

  44. Meyers S, Mayer L, Bottone E, et al. 1981. Occurrence of clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology 80: 697–700.

    PubMed  CAS  Google Scholar 

  45. Wright JM, Adams SP, Gribble MJ, and Bowie WR. 1984. Clostridium difficile in Crohn’s disease. Cancer J Surgery 27(5): 435–7.

    CAS  Google Scholar 

  46. Dorman SA, Liggoria E, Winn Jr., WC, and Beeken WL. 1982. Isolation of Clostridium difficile from patients with inactive Crohn’s disease. Gastroenterology 82: 1348–51.

    PubMed  CAS  Google Scholar 

  47. Rolny P, Jarnerot G, and Mollby R. 1083. Occurrence of Clostridium toxin in inflammatory bowel disease. Scand J Gastroenterol l8(1): 61–4.

    Google Scholar 

  48. Greenfield C, Aguilar Ramirez JR, Pounder RE, Williams T, Danvers M, Marper SR, and Noone P. 1983. Clostridium difficile and inflammatory bowel disease. Gut 24, 713–717.

    Article  PubMed  CAS  Google Scholar 

  49. Falsen E, Kayser B, Nehis L, et al. 1980. Clostridium difficile in relation to enteric bacterial pathogens. J Clin Microbiol 12: 297–300.

    PubMed  CAS  Google Scholar 

  50. Gilligan PH, McCarthy LR, Genta VM. 1981. Relative frequency of Clostridium difficile in patients with diarrheal disease. J Clin Microbiol 14: 26–30.

    PubMed  CAS  Google Scholar 

  51. Chang TO, Lauerman M, and Bartlett JG. 1979. Cytotoxicity assay in antibiotic-associated colitis. Journal of Infectious Diseases 140: 756–70.

    Google Scholar 

  52. Bartlett JG. 1981. Clostridium difficile and inflammatory bowel disease (Editorial). Gastroenterology 80: 863–875.

    PubMed  CAS  Google Scholar 

  53. Parent K, Mitchell P. 1976. Bacterial variants: etiologic agent in Crohn’s disease? Gastroenterology 71: 365–68.

    PubMed  CAS  Google Scholar 

  54. Parent K, Mitchell P. 1978. Cell wall defective variants of Pseudomonas-like (Group Va) bacteria in Crohn’s disease. Gastroenterology 75: 368–72.

    PubMed  CAS  Google Scholar 

  55. Parent K, Mitchell P, and Baltaos E. 1980. Pilot animal pathogenicity studies with cell wall defective pseudomonas-like bacteria isolated from Crohn’s disease patients. Abstract. Gastroenterology 78: 1233.

    Google Scholar 

  56. Belsheim MR, Darwish RZ, Watson WC, and Schieven B. 1983. Bacterial L-form isolation from inflammatory bowel disease patients. Gastroenterology 85: 364–68.

    PubMed  CAS  Google Scholar 

  57. Graham DY, Yoshimura HH, and Estes MK. 1983. DNA hybridization studies of the association of Pseudomonas maltophilia with inflammatory bowel disease. J Lab Clin Med 101: 940–54.

    PubMed  CAS  Google Scholar 

  58. Whorwell PJ, Davidson IW, Beeken WL, and Wright R. 1978. Search by immunofluorescence for antigens of Rotavirus, Pseudomonas maltophilia, and Mycobacterium kansasii in Crohn’s disease. Lancet 2 (8092 Pt l: 697–8.

    Article  PubMed  CAS  Google Scholar 

  59. Shafii A, Sopher S, Lev M, and Das KM. 1981. An antibody against revertant forms of cell-wall deficient bacterial variant in sera from patients with Crohn’s disease. Lancet 2(8242): 332–4.

    Article  PubMed  CAS  Google Scholar 

  60. Onderdonk AB, Franklin ML, and Cisneros RL. 1981. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infection and Immunity 32(1): 225–31.

    PubMed  CAS  Google Scholar 

  61. Onderdonk AB, and Bartlett JG. 1979. Bacteriological studies of experimental colitis. The American Journal of Clinical Nutrition 32: 258–2655.

    PubMed  CAS  Google Scholar 

  62. Burnham WR, Lennard-Jones JE, Stanford et al. 1978. Mycobacteria as a possible cause of inflammatory bowel disease. Lancet 2: 693–96.

    Article  PubMed  CAS  Google Scholar 

  63. Stanford JL. 1978. Mycobacteria as a possible cause of inflammatory bowel disease. Lancet 693–96.

    Google Scholar 

  64. Stanford JL. 1981. Acid fast organisms in Crohn’s disease and ulcerative colitis. In Recent Advances in Crohn’s Disease. AS Pena, IT Weterman, CC Booth, W Strober (eds). The Hague, Martinus Nijhoff Publishers, pp 278–282.

    Google Scholar 

  65. White SA: Investigation into the density of acid fast organisms located from Crohn’s disease. 1981. In Recent Advances in Crohn’s Disease. AS Pena, IT Weterman, CC Booth, W Strober (eds). The Hague, Martinus, Nijhoff Publishers, pp 278–282.

    Google Scholar 

  66. White S. Nassau E, and Burnham W. and Stanford J. 1978. Lennard-Jones JE: Further evidence for a mycobacterial aetiology of Crohn’s disease. Gut 19: A443–444.

    Article  Google Scholar 

  67. Chiodini RJ, Van Kruiningen HJ, Thayer WR, Merkal R, and Coutu JA. 1984. Possible role of mycobacteria in inflammatory bowel disease. Digestive Diseases and Sciences, Vol. 29, No 12, pp 1073–1079.

    Article  PubMed  CAS  Google Scholar 

  68. Van Kruiningen HJ, Chiodini RJ, Thayer WR, Coutu JA, Merkal RS, and Runnels PL. Experimental disease in goats induced by mycobacterium from a patient with Crohn’s disease. Gastroenterology 30: A–122, 1985. Abstract No. 487.

    Google Scholar 

  69. Thayer WR, Coutu JA, Chiodini RJ, Van Kruiningen HJ, and Merkal R. 1984. Possible role of mycobacteria in inflammatory bowel disease. II Mycobacterial antibodies in Crohn’s disease. Digestive Diseases and Sciences, Vol. 29, No. 12, pp. 1080–1085.

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Martinus Nijhoff Publishers

About this chapter

Cite this chapter

Gorbach, S.L. (1986). Bacterial Etiology of Inflammatory Disease. In: Rachmilewitz, D. (eds) Inflammatory Bowel Diseases 1986. Developments in Gastroenterology, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4269-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4269-1_2

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8396-6

  • Online ISBN: 978-94-009-4269-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics